Credits of many drug companies rated up.

Many drug companies have been rated higher in their credits according to the overall reviews by the National Informations and Credit Evaluation Inc. (NICE) and other evaluation organizations including KIS and KMCC.

Compared over June last year, companies like Dong-A, Green Cross, Yuhan, Choongwe, Kwangdong, Boryung and Pacific were rated higher in their credit scores during the same ...